News From A Colorful Perspective
Ensuring diversity and inclusivity in the workplace doesn’t just happen, individuals and organizations must take action to do things differently. Johnson& Johnson, The Hershey Company and EY created a coalition aimed at creating opportunities to advance people of color in supply chain jobs that plan, source, make and deliver products….
Originally Published by Johnson & Johnson Analysis shows consistent renal and cardiovascular benefit when treated with INVOKANA® even when patients had moderate to severe renal deficiency INVOKANA® is the only diabetes medicine indicated to slow the progression of diabetic nephropathy (also known as DKD) and reduce the risk of hospitalization for heart…
Originally Published by Johnson & Johnson Johnson & Johnson (NYSE: JNJ), the world’s largest and most broadly-based healthcare company, today published You Belong: Diversity & Inclusion Impact Review (Impact Review), which demonstrates how a strategic Diversity & Inclusion (D&I) philosophy has been a key driver of innovation and impactful business outcomes since…
The first time I realized mental illness could hinder my career, I was a sophomore in college. The first semester of that year yielded a diagnosis of generalized anxiety disorder and moderate depression, but it was also when I got involved in writing for my college’s newspaper and truly developed…
Originally Published by Johnson & Johnson Johnson & Johnson today announced it has committed to ensuring more than $500 million is dedicated to world class research & development and delivery programs over the next four years to accelerate global efforts to eliminate HIV and tuberculosis (TB) by 2030. As one…
National Suicide Prevention Week runs from Sept. 8–14 to raise awareness about suicide and the resources available to help those struggling with mental health crises. However, certain demographics seem to consistently slip through the cracks of mental health education, advocacy and care. People of color in the United States suffer…
Originally posted on JNJ.com The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new results from the Phase 3 EINSTEIN-Jr study, showing pediatric patients (aged birth to 17 years) treated with XARELTO® (rivaroxaban) had a similar low risk of recurrent venous thromboembolism (VTE) – or blood clots – and similar…
Data presented at the American Psychiatric Association 2019 Meeting suggest a low rate of psychiatric care received by adult patients with MDD before suicide ideation or attempt diagnosis Originally Published by Johnson & Johnson. Additional Data Show Patients Have a High Risk of Hospital Readmission or Subsequent Emergency Department Visit…
Sponsorship is essential to advance women and people of color into senior leadership positions. “We now have almost 400 people in our sponsorship program globally… These were all high performing people for a long period of time. They were all people we knew had upward mobility,” said Nancy Wolfe, SVP,…
Up to 70% of nurses and nearly 55% of physicians report symptoms of burnout, which costs workplaces millions of dollars a year due to lost productivity and employee turnover and absenteeism—and impacts patient quality of care. But the CareAdvantage program is poised to help. By Kristen Mascia Originally Published by…
Get the content you love the most directly in your email inbox.